ArticleJournal of translational medicine2023

Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1.

Hongpei Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.